Aptose Biosciences Inc.

Reported to SECin USCIK 0000882361Filings at SEC EDGAR

No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent Form 4 lines at this company, out of 72. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.

5 of 72
Form 4 lines at Aptose Biosciences Inc., most recent filing first
Filed byTypeValueReportedFiled byValueTypeSharesReported
Seizinger Bernd R.—Returned to the issuernothing paid50,000 sharesJul 2, 2026Seizinger Bernd R.nothing paidReturned · Jul 2Returned to the issuer50,000Jul 2, 2026
Seizinger Bernd R.—Returned to the issuernothing paid100,000 sharesJul 2, 2026Seizinger Bernd R.nothing paidReturned · Jul 2Returned to the issuer100,000Jul 2, 2026
Seizinger Bernd R.—Returned to the issuernothing paid3,333 sharesJul 2, 2026Seizinger Bernd R.nothing paidReturned · Jul 2Returned to the issuer3,333Jul 2, 2026
Seizinger Bernd R.—Returned to the issuer$29,24017,000 sharesJul 2, 2026Seizinger Bernd R.$29,240Returned · Jul 2Returned to the issuer17,000Jul 2, 2026
Whitehead Warren—Returned to the issuernothing paid53,000 sharesJul 1, 2026Whitehead Warrennothing paidReturned · Jul 1Returned to the issuer53,000Jul 1, 2026